Company: ZVRA
Filing Date: 2025-11-05
Form Type: 10-Q
Source: 0001434647-25-000011
Chunk: 81

Company: ZEVRA THERAPEUTICS, INC.
Filing Date: 2025-11-05
Form: 10-Q
Item: Part I, Item 1
Chunk 81
---
 months ended September 30, 2025, is as follows (in thousands):Three Months EndedSeptember 30, 2025Nine Months EndedSeptember 30, 2025Basic net (loss) income per share of common stock:Net (loss) income$(544)$71,064 Earnings allocated to participating securities— (5,309)Net (loss) income attributable to shares of common stock(544)65,755 Less: Dividends declared or accumulated— — Undistributed net (loss) income attributable to shares of common stock, basic(544)65,755 Weighted-average shares of common stock outstanding55,952 54,949 Basic net (loss) income per share of common stock$(0.01)$1.20 Diluted net (loss) income per share of common stock:Net (loss) income attributable to shares of common stock$(544)$65,755 Less: Fair value adjustment income related to warrant liability— — Net (loss) income attributable to shares of common stock, diluted(544)65,755 Weighted-average number of shares of common stock outstanding55,952 54,949 Dilutive effect of outstanding stock options (as converted to common stock)— 1,834 Weighted-average shares of common stock outstanding, diluted55,952 56,783 Diluted net (loss) income per share of common stock$(0.01)$1.16 

K.    LeasesThe Company has operating and finance leases for office space, laboratory facilities and various laboratory equipment, furniture and office equipment and leasehold improvements. The Company determines if an arrangement is a lease at contract inception. Lease assets and lease liabilities are recognized based on the present value of lease payments over the lease term at the commencement date. The Company does not separate lease and non-lease components. Leases with a term of 12 months or less at commencement are not recorded on the unaudited condensed consolidated balance sheets. Lease expense for these arrangements is recognized on a straight-line basis over the lease term. The Company’s leases have remaining lease terms of approximately 1 year and up to approximately 3 years, and some which include options to terminate the leases within 1 year.The components of lease expense were as follows (in thousands): Three months ended September 30,Nine months ended September 30,Lease Cost2025202420252024Finance lease cost:Amortization of right-of-use